Treatment Efficacy of MEDI3902 in Pseudomonas aeruginosa Bloodstream Infection and Acute Pneumonia Rabbit Models

Pseudomonas aeruginosa is a challenge for clinicians due to increasing drug resistance and dwindling treatment options. We report on the activity of MEDI3902, an antibody targeting type 3 secretion protein PcrV and Psl exopolysaccharide, in rabbit bloodstream and lung infection models. MEDI3902 prop...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antimicrob Agents Chemother
Auteurs principaux: Le, Hoan N., Tran, Vuvi G., Vu, Trang T. T., Gras, Emmanuelle, Le, Vien T. M., Pinheiro, Marcos Gabriel, Aguiar-Alves, Fábio, Schneider-Smith, Erika, Carter, Henry Clay, Sellman, Bret R., Stover, C. Kendall, DiGiandomenico, Antonio, Diep, Binh An
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2019
Sujets:
Experimental Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6658784/
https://ncbi.nlm.nih.gov/pubmed/31160288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00710-19
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires